Durvalumab (MEDI4736) and TREmelimumab in NEOadjuvant Bladder Cancer Patients (DUTRENEO)
Clinical trial NCT03472274 · COMPLETED
Trial details
- NCT number
- NCT03472274
- Sponsor
- Fundacion CRIS de Investigación para Vencer el Cáncer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-25
- Primary completion
- 2021-04-30
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.